Curated News
By: NewsRamp Editorial Staff
March 04, 2026
Earth Science Tech Reports Strong Q3 Growth, Expands Telemedicine Platform
TLDR
- Earth Science Tech's Q3 revenue growth and Peaks telemedicine success offer investors a strategic advantage in scaling healthcare operations across multiple jurisdictions.
- ETST expanded revenue by 14.1% with improved margins while implementing PCAOB auditing to manage increasing accounting complexity as it pursues state licenses.
- ETST's telemedicine platform provides faster, personalized healthcare access while maintaining strong compliance, making quality care more accessible and responsibly managed.
- Earth Science Tech's Peaks telemedicine platform generated over $2 million in under a year, showing rapid adoption in the evolving virtual care market.
Impact - Why it Matters
This news matters because it highlights how healthcare companies are navigating the complex balance between rapid growth and responsible governance. Earth Science Tech's performance demonstrates that telemedicine platforms like Peaks are achieving significant revenue quickly, indicating strong consumer adoption of virtual healthcare services. The company's expansion into new states and its focus on compliance through PCAOB auditing show how healthcare operators must scale while meeting increasing regulatory demands. For investors and industry observers, this represents a model of how healthcare companies can grow through strategic acquisitions while maintaining financial discipline—a critical consideration as the healthcare sector continues to consolidate and face heightened scrutiny. The company's success in expanding gross margins while growing revenue suggests effective management of its diverse portfolio, offering insights into sustainable growth strategies in the competitive healthcare market.
Summary
Earth Science Tech (OTC: ETST), a strategic healthcare holding company, reported strong fiscal Q3 2026 results, with revenue reaching $8.4 million—a 14.1% year-over-year increase. The company's financial health is further highlighted by an expanded gross margin of 76.3% and adjusted EBITDA rising to $1.2 million. A key driver of this growth is the company's telemedicine platform, Peaks, which has surpassed $2.0 million in revenue in less than a year, demonstrating rapid market adoption. Management is actively pursuing additional state licenses to expand its geographic footprint, positioning the company for continued expansion in the competitive telemedicine space.
In a significant governance move, Earth Science Tech has engaged Semple, Marchal and Cooper, LLP as its independent PCAOB auditor. This decision is framed as necessary to handle increasing consolidated accounting complexity as the company scales its multi-subsidiary operations. The company operates as a strategic holding company that builds value by acquiring and actively managing operating businesses across pharmaceuticals, telemedicine, healthcare services, real estate, and select consumer markets. Its focus is on scaling responsibly across different jurisdictions and clinical workflows while maintaining strict governance and financial discipline—a crucial differentiator in today's healthcare landscape where consumer demand for faster, personalized care must be balanced with institutional requirements for compliance and audit readiness.
The broader context reveals how Earth Science Tech is executing a playbook that addresses two fundamental forces reshaping healthcare delivery: accelerating consumer demand for accessible, personalized care and the growing institutional need for robust compliance frameworks. As telemedicine adoption becomes normalized and pharmacy models compete on speed and regulatory execution, companies like Earth Science Tech that can scale while maintaining control are positioned for success. For more detailed insights into how the company is building its multi-unit healthcare platform, readers can explore the comprehensive coverage available through BioMedWire, a specialized communications platform within the Dynamic Brand Portfolio @ IBN that focuses on biotechnology and life sciences sectors.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Earth Science Tech Reports Strong Q3 Growth, Expands Telemedicine Platform
